Clinical Study
Survival Advantage Associated with Decrease in Stage at Detection from Stage IIIC to Stage IIIA Epithelial Ovarian Cancer
Table 2
Demographic data Stage IIIA versus Stage IIIC epithelial ovarian cancer, University of Kentucky Markey Cancer Center 2000–2009.
| | | IIIA | IIIC | Significance |
| | | Mean | Mean | |
| | Age at diagnosis | | | | | Number of live births at diagnosis | | | |
| | | | | |
| | Race | | | | | Black | 0 | 1 (0.5%) | | | White | 15 (100%) | 185 (99.5%) | | | Other | 0 | 0 | | | Appalachian Region | | | | | Appalachia | 8 (53%) | 115 (62%) | | | Non-Appalachia | 7 (47%) | 71 (38%) | | | Urban region | | | | | Rural | 5 (33%) | 70 (38%) | | | Urban | 10 (67%) | 116 (62%) | | | Cell type | | | | | Serous carcinoma | 8 (54%) | 118 (63%) | | | Endometrioid carcinoma | 3 (20%) | 17 (10%) | | | Mixed adenocarcinoma (NOS) | 2 (13%) | 36 (19%) | | | Clear cell, mucinous, carcinoma (NOS) | 2 (13%) | 15 (8%) | |
|
|
NOS: not otherwise specified.
|
